In 2019, the Kidney Cancer Association announced $1 million in new research funding for two annual $500,000 grants targeting the early detection and innovative treatments for kidney cancer.
The Advanced Discovery Award (ADA) seeks to promote collaboration between a clinician including a urologic oncologist, medical oncologist or radiation oncologist and a research-based collaborator (Ph.D., M. D., D. O.) to propose new research that will make an immediate impact in the field of kidney cancer.
Research may include biomarker development, development of novel therapeutic targets, correlative studies associated with ongoing or completed clinical trials, or assays that promote the early detection of kidney cancer. Any and all proposals are evaluated through the Letter of Intent (LOI) Process.
The KCA looks forward to reviewing innovative applications from the kidney cancer research community and learning how their projects will continue advancing our mission of bringing an end to the death and suffering from renal cancers and envisioning of a world without kidney cancer.
All questions regarding the grant application process should be submitted to [email protected].